Institutional investors hold a majority ownership of PCRX through the 109.91% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2016, these large investors purchased a net $548.1 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PARTNER FUND MANAGEMENT LP Bought 1.2 Million shares of Pacira Pharmaceuticals In...